These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8011150)
1. Regulation of the immune response within privileged sites. Ksander BR; Streilein JW Chem Immunol; 1994; 58():117-45. PubMed ID: 8011150 [No Abstract] [Full Text] [Related]
2. HLA Class I protein expression in the human placenta. Blaschitz A; Hutter H; Dohr G Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519 [TBL] [Abstract][Full Text] [Related]
4. Maternal and fetal immune responses during pregnancy. Sargent IL Exp Clin Immunogenet; 1993; 10(2):85-102. PubMed ID: 8251183 [TBL] [Abstract][Full Text] [Related]
5. Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance? Liu Y; Zheng P Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S61-4. PubMed ID: 11665749 [TBL] [Abstract][Full Text] [Related]
10. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis. Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291 [TBL] [Abstract][Full Text] [Related]
11. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta. Davies CJ; Hill JR; Edwards JL; Schrick FN; Fisher PJ; Eldridge JA; Schlafer DH Anim Reprod Sci; 2004 Jul; 82-83():267-80. PubMed ID: 15271459 [TBL] [Abstract][Full Text] [Related]
17. Immune interactions at the maternal-fetal interface: a focus on antigen presentation. Huddleston H; Schust DJ Am J Reprod Immunol; 2004 Apr; 51(4):283-9. PubMed ID: 15212681 [TBL] [Abstract][Full Text] [Related]
18. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. Hara Y; Okamoto S; Rouse B; Streilein JW J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216 [TBL] [Abstract][Full Text] [Related]
19. Fetomaternal immunotolerance. Makrigiannakis A; Karamouti M; Drakakis P; Loutradis D; Antsaklis A Am J Reprod Immunol; 2008 Dec; 60(6):482-96. PubMed ID: 19032609 [TBL] [Abstract][Full Text] [Related]
20. The involvement of HLA-E and -F in pregnancy. Ishitani A; Sageshima N; Hatake K J Reprod Immunol; 2006 Apr; 69(2):101-13. PubMed ID: 16487601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]